1
/
of
0
FDA Drug Approval, N050724, ABELCET
FDA Drug Approval, N050724, ABELCET
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 050724
Company: LEADIANT BIOSCI INC
Drug Name: ABELCET
Active Ingredients: AMPHOTERICIN B
Strength: 5MG/ML
Dosage Form/Route: INJECTABLE, LIPID COMPLEX;INJECTION
Action Date: 11/20/1995
Marketing Status: Prescription
Submission Classification: Type 2 - New Active Ingredient
Company: LEADIANT BIOSCI INC
Drug Name: ABELCET
Active Ingredients: AMPHOTERICIN B
Strength: 5MG/ML
Dosage Form/Route: INJECTABLE, LIPID COMPLEX;INJECTION
Action Date: 11/20/1995
Marketing Status: Prescription
Submission Classification: Type 2 - New Active Ingredient
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details